Skip to main content

Wednesday, 8 Sep 2021

Room: Main Lecture Hall, Muses Area (Level 3)

Time Session Speaker
08.00–08.15 Welcome and Introduction C. Taschner, DE

J. Fiehler, DE

08.15–09.30 Scientific Abstracts

Chairs: C. Cognard, FR; W. van Zwam, NL

  Collateral damages of COVID-19 on the Hungarian ischemic stroke care P.P. Böjti, HU
  Utility of drug-eluting Coroflex ISAR Stent in intracranial atherosclerotic disease: A single center experience in 147 patients A. El Mekabaty, DE
  Single Center Experience Utilizing a Novel Augmented Reality Platform to Teleproctor a Neuroendovascular Fellow S. Desai, US
  The Subarachnoid Hemorrhage Early Brain Edema Score (SEBES) as radiographic marker of clinically relevant intracranial hypertension and unfavorable outcome after subarachnoid hemorrhage. M. Said, DE
  Long-term results of complex wide-necked intracranial aneurysms treated with stent-assisted coiling using low-profile Acandis Acclino stent systems D. Grieb, DE
  Vessel Wall MRI Findings Improve Specificity for Detection of Delayed InStent Stenosis following Flow Diversion of Unruptured Aneurysms M. Alexander, US
  The neglected arachnoid trabeculae: An in-vivo preliminary feasibility study with use of trans-vascular OCT imaging to explore the perivascular subarachnoid space V. Anagnostakou, CH
  Endovascular Treatment of Anterior Cranial Fossa Fistulas: The Significance of Retrograde Transvenous Approach B. Pabon, CO
  A Retrospective Case Series of Tectal Arteriovenous Malformations: Clinical Characteristics, Angioarchitecture Description and Therapeutic Management J. Cortese, FR
09.30–10.00 Industry Symposium Siemens Healthineers  
  Direct-to-Angio: Save time and improve patient outcome for acute stroke patients M. Psychogios, CH
10.00–10.30 Coffee Break  
10.30–12.00 Joint Meeting with EANS Vascular Section – Part 1: Vasospasm

Chairs: Z. Kulcsár, CH; C. Cognard, FR

  Unruptured intracranial aneurysms: Development, rupture, and preventive management N. Etminan, DE
  Pathophysiology of post-subarachnoid hemorrhage (SAH) vasospasm A. Gruber, AT
  Trials on prevention of post-SAH vasospasm N. Hecht, DE
  Endovascular therapy of post-SAH vasospasm: What is the evidence? P. Bhogal, UK
  Timing of endovascular therapy for post-SAH vasospasm R. Helbok, AT
12.00–12.30 Scientific Abstracts

Chairs: A. Gruber, AT; C. Taschner, DE

  Early Cerebral infarction following aneurysmal subarachnoid hemorrhage is associated with prior circulatory failure and severe intracranial hypertension D. Simonato, UK
  Intensive therapies of delayed cerebral ischemia targeting vasospasm: a two-center propensity-matched study D. Simonato, UK
  Efficacy and Safety in the Use of Stent-Retrievers for Treatment of Cerebral Vasospasms after Subarachnoid Hemorrhage J. Hensler, DE
12.30–13.00 Industry Symposium Balt

Chair: A. Rouchaud, FR

  Catchview Thrombectomy device in AIS Y. Onal, TR
  Vall d’Hebron experience with Catchview in AIS A. Tomasello, ES
13.00–14.00 Lunch Break  
14.00–14.30 Industry Symposium Microvention  
  Aneurysm treatment with WEB in the cumulative population of two prospective, multicenter series: 5-year follow-up L. Pierot, FR
  Clinical Evaluation of WEB 0.017 Device in Intracranial AneuRysms (CLEVER): Study Demographics C. Cognard, FR
14.30–15.30 Joint Meeting with SNIS – Part 1: Aneurysm

Chairs: L. Valvassori, IT; L. Pierot, FR

  Debate MCA bifurcation aneurysms: Stent assisted coiling/flow diverter vs Web device

We should use Stent-assisted coiling / Flow diverters to treat those

Intrasaccular flow disruptors are the way to go


J. Mocco, US

C. Cognard, FR

  Surface modified flow diverters: the future of flow-diversion? H. Henkes, DE
  Intrascaccular flow-disruptors in the treatment of ruptured aneurysms A. Rai, US
15.30–16.00 Scientific Abstracts

Chairs: V. Kalousek, HR; M. Bester, DE

  Pipeline Embolization Devices for the Treatment of Intracranial Aneurysms (PEDESTRIAN), Single Centre Registry: Long-Term Angiographic and Clinical Outcomes from 1,000 Aneurysms I. Lylyk, AR
  Accuracy Evaluation of Derivo Flow Diverter Deployed Length Predictions with PreSize Neurovascular and Comparison of Device Size Selection between Traditional Planning and Simulations N.T. Ngo, DE
  Safety and Efficacy of Eptifibatide for endovascular intracranial aneurysm treatment T. Schubert, CH
16.00–16:30 Coffee Break  
16.30–16.45 Industry Symposium Penumbra  
  ADAPT to the Situation: Why start with aspiration for distal occlusions P. Schramm, DE
16.45–18.30 Joint Meeting with SNIS – Part 2: New Horizons

Chairs: M. Möhlenbruch, DE

  Spontaneous intracranial hypotension (SIH): Pathophysiology and surgical treatment J. Beck, DE
  Imaging of SIH and SIH treatment with epidural blood patches H. Urbach, DE
  CSF-Venous fistulae: A frequent cause of SIH and their endovascular therapy W. Brinjikji, US
  Debate on middle menigeal artery (MMA) embolization for chronic subdural hematomas (cSDH)

We should favor liquid embolic agents

Follow the KISS principle: Use particles


D. Fiorella, US

Z. Kulcsár, CH

  Remote proctoring for neurointerventional procedures M. Bester, DE
  Neurovascular robotics in treatment of intracranial aneurysms V. Mendes Pereira, CA
18.30–19.30 ESMINT General Assembly  

EYMINT Meeting: Young Interventionalists@ESMINT Congress 2021

Chairs: U. Hanning, DE; A. Rouchaud, FR

Room: Gallieni 1+2 (Level 2)

Time Session Speaker
08.30–10.00 EYMINT Session – Part 1  
  Applied Neuroanatomy of the dangerous anastomoses for SDH embolization, dural fistulas, etc. E. Shotar, FR
  Intracranial hypo- and hypertension E. Piechowiak, DE
  Update and experiences of the EYMINT e-Fellowship program U. Hanning, DE
  Collaborative research network G. Boulouis, FR
  Round table, what do you expect from EYMINT? Perspectives from the Younicorn and the JENI Networks G. Boulouis, FR
U. Hanning, DE
L. Meyer, DE
J. Cortese, FR
10.00–10.30 Coffee Break  
10.30–13.00 EYMINT Session – Part 2  
  Neurorobotics/Basecamp R. Blanc, FR
  Distal occlusions L. Meyer, DE
  Intracranial stenosis P. Mordasini, CH
  AI: Quantitative image analysis using machine learning algorithms current applications and future perspectives H. Kniep, DE
  Imaging of neuroendovascular devices: interpretation and challenges M.T. Nawka, DE
  Embolization subdural hematomas J.C. Gentric, FR

ETMINT Symposium for Angiosuite Personnel – Technicians, Nurses & Radiographers in cooperation with ESMINT

Room: Gallieni 1+2 (Level 2)

Time Session Speaker
14.00–16.00 ETMINT Session – Part 1

Chairs: J. Ducasse, FR; F. Menu, FR

  Opening F. Menu, FR; M. Gawlitza, DE
  Diversity of embolic agents for the treatment of cerebral arterioveinou
J. Ducasse (NRT), FR
  Vaso CT: An essential application in Interventional Neuroradiology J. Ducasse (NRT), FR, P. Bernardin (NRT), FR
  How dangerous are unruptured intracranial aneurysms? M. Gawlitza (MD), DE
  Stroke pathway: Diagnostic paradigm at Parma University Hospital C. Martini (NRT), IT
  Stroke techniques and material overview D. Behm (MD), DE
16.00–16.30 Coffee Break  
16.30–18.00 ETMINT Session – Part 2

Chairs: A.C. Januel, DE; H. Genins, SE

  Interventional treatment of epistaxis M. Gawlitza (MD), DE
  Flow disrupter – current status L. Pierot (MD), FR
  Secrets of your own radiation protection: For your eyes only S. Balduyck (MD), FR
  Organization prior to intervention in NHS practice in UK! What you need to do. H. Birch (NRT), UK, T. Patankar (MD), UK
  Correlation between vascular anatomy, occlusion site and neurological outcome following EVT of LVO G. Gál (MD), DK

Thursday, 9 Sep 2021

Room: Main Lecture Hall, Muses Area (Level 3)

Time Session Speaker
08.00–09.00 Joint Meeting with ESO – Part 1: EVT for LVO 1

Chairs: M. Ribo, ES; W. van Zwam, NL

  Utility of Neurosonology before during and after endovascular therapy (EVT) for large vessel occlusion (LVO) C. Krogias, DE
  Optimal BP management before during and after EVT for LVO A. Katsanos, CA
  Mechanical thrombectomy in minor stroke with LVO A. Sarraj, US
  Bridging therapy in LVO: fact or fiction? G. Tsivgoulis, GR
09.00–09.30 Scientific Abstracts

Chairs: A. Rouchaud, FR; M. Psychogios, CH

  Burden of Tough to Retrieve Clots in Acute Ischemic Stroke: Clinical and Economic Impact of Increasing Retrieval Attempts in Mechanical Thrombectomy J. Alderson, IE
  First Pass Effect and Associated Clot Characteristics in the EXCELENT Registry – Interim Analysis T. Jovin, US
  Beyond Proximal Large Vessel Occlusions: Outcome of Mechanical Thrombectomy in Distal Vessel Occlusions in the EXCELENT Registry – Interim Analysis O. Zaidat, US
09.30–10.00 Industry Symposium Cerenovus  
  The NIMBUS™ Geometric Clot Extractor: Can we predict Real World Experience through In-Vitro testing? M. Gounis, US
H. Nordmeyer, DE
P. Mordasini, CH
10.00–10.30 Coffee Break  
10.30–11.30 Joint Meeting with ESO – Part 2: EVT for LVO 2

Chairs: J. Gralla, CH; A. Krajina, CZ

  Neuroprotection following EVT for LVO: Fact or fiction? P. Schellinger, DE
  EVT for Basilar Artery Occlusion: Rescue or evidence-based therapy? D. Strbian, FI
  Pretreatment with oral anticoagulants in LVO patients receiving EVT: practical considerations in post-procedural management G. de Marchis, CH
  Management of reocclusion in LVO patients treated with EVT M. Rubiera del Fueyo, ES
11.30–12.30 Scientific Abstracts

Chairs: E. Ciceri, IT; K. Zelenak, SK

  The Novel Tenzing Inserts – The Seamless Way To Reach The Clot In Large And Middle Vessel Cerebral Occlusions – Preliminary Experience M. Gounis, US
  Catheter tip distensibility substantially influences the aspiration force of thrombectomy devices J. Li, ES
  Nimbus Geometric Clot Extractor for Tough Clots – Real World Clinical Experience and Clot Composition H. Nordmeyer, DE
  Initial experience with the Trevo NXT stent retriever M.N. Psychogios, CH
  Investigation of current and novel treatment strategies for ICA and MCA occlusions in an in-vitro thrombectomy model S. Fitzgerald, IE
  Safety and Effectiveness of Mechanical Thrombectomy for Primary Isolated Distal Vessel Occlusions: a Monocentric Retrospective Comparative Study M. Elhorany, FR
  Hemorrhagic Transformation and First Pass Effect G. Meeks, US
12.30–13.00 Industry Symposium Medtronic  
  Shield Technology™ – Trust the Science; 1 year results 400 patients treated with Pipeline™ Flex with Shield Technology™ in INSPIRE I. Szikora, HU
  Pipeline™ Flow Diversion Reimagined; Early clinical experience with the fourth generation Pipeline™ Vantage with Shield Technology™ – First Experience R. Rautio, FI
13.00–14.00 Lunch Break  
14.00–14.30 Industry Symposium Stryker  
  Enhanced retrieval experience with Trevo NXT ProVue Retriever N. Limbucci, IT
  ADAPT 3.0: Evolution of direct aspiration A. Spiotta, US
14.30–15.00 JNIS Meets ESMINT – ESMINT’s Award for best European publication in JNIS

Chairs: M. Aggour, UK; J. Fiehler, DE

  Insight in JNIS F. Albuquerque, US
  Award for the Best European Publication in JNIS M. Aggour, UK
P. White, UK
J. Fiehler, DE
  ESMINT’s Award Winner: Presentation and Discussion  
15.00–15.15 ESMINT Diploma Award Ceremony

Chairs: M. Gawlitza, DE; J. Fiehler, DE

15.15–15.35 Honorary Membership

Chairs: J. Fiehler, DE; Z. Kulcsár, CH, A.C. Januel, FR

  Presentation E. Boccardi, IT
15.35–16.15 Scientific Abstracts

Chairs: A. Biondi, FR; P. Mordasini, CH

  Which Transfer Patients with Stroke due to a Large-Vessel Occlusion benefit from CT scan reevaluation prior to Mechanical Thrombectomy? J.A. Sousa, PT
  Use Of The New Philips’ Advanced 3D Neuro-Imaging For LVO Triaging And Door To Puncture Times Reductions M. Gounis, US
  Unbiased mTICI scoring after acute ischemic stroke: An image-processing based semi-automatic grading method M. Thormann, DE
  GRINT: Guidelines for Reporting in Interventional Neurological Therapy – Flow diverters M. ten Brinck, NL
16.15–16.30 Coffee Break  
16.30–16.45 Industry Symposium Phenox  
  Diversion-p64- Results of the multicentre, prospective, international study M. Bonafé, IT
16.45–17.00 Industry Symposium Philips  
  Direct to Angio Suite: Why and How. Sharing experiences from the WETRUST study M. Ribo, ES
17.00–18.00 Evidence for New Medical Devices

Chairs: C. Taschner, DE; W. van Zwam, NL

  Debate on Evidence for New Medical Devices: What do we need?  
  Randomized controlled trials are the way to go H. Lingsma, NL
  We should have a more pragmatic approach: Registry trials J. Fiehler, DE
  Medical device reagulation in Europe: Expert panels and clinical evidence C. Griesinger, IT

Friday, 10 Sep 2021

Room: Main Lecture Hall, Muses Area (Level 3)

Time Session Speaker
08.30–09.30 The diseased vessel wall

Chairs: A.C. Januel, FR; F. Dorn, DE

  From the neuropathologists perspective: Overview on the diseased intracranial vessel D. Thal, BE
  Aneurysm wall and risk of rupture B. Rezai-Jahromi, FI
  Direct visualization of the vessel wall with OCT M. Gounis, US
09.30–10.00 Industry Symposium Siemens Healthineers  
  Impact of Robotic Surgery in Neurovascular R. Turner, US
M. Piotin, FR
10.00–10.30 Coffee Break  
10.30–11.30 Joint Meeting with EANS Vascular Section – Part 2: AVM

Chairs: S. Lamin, UK; L. Spelle, FR

  Unruptured brain AVM: Do we have an answer? T. Meling, CH
  Curative treatment of intracranial AVMs:

We don’t need pre-operative embolization

We don’t need post-embolization surgery


A. Raabe, CH

R. Chapot, DE

11.30–12.00 Best European Studies

Chairs: T. Patankar, UK; K. Zelenak (SK)

  Coating to Optimize Aneurysm Treatment In The New Flow Diverter Generation (COATING): Study protocol of a randomized controlled trial L. Pierot, FR
  Solitaire With the Intention For Thrombectomy Plus Intravenous t-PA Versus DIRECT Solitaire Stent-retriever Thrombectomy in Acute Anterior Circulation Stroke (SWIFT DIRECT). Results for a randomized-controlled trial J. Gralla, CH
12.00–13.00 New Technology Symposium: The engineers’ perspective

Chairs: J.H. Buhk, DE; M. Gounis, US

  Contour™ Neurovascular System: Besançon 1 year experience A. Biondi, FR
  Solitaire™ 3mm  
  PEGASUS HPC – First clinical experience with a new coated intracranial Stent M. Holtmannspötter, DE
  Introducing NeVa NET, the next frontier in thrombectomy D. Behme, DE
13.00–14.00 Lunch Break  
14.00–16.00 Morbimortality Corner

Chairs: C. Cognard, FR; R. Chapot, DE

  Radionecrosis as a consequence of cumulative effect of endovascular and radiosurgical treatments for intracranial AVMs M. Cenzato, IT
  Right ICA Viabahn Covered Stent Extrusion into the Oropharynx E. Chishti, US
  Complete oculomotor nerve palsy after dural arteriovenous embolization through middle meningeal artery: a very rare complication G. Barchetti, IT
  Torn basilar artery J.H. Buhk, DE
  Complex residual Posterior fossa dural fistula embolisation with Mini sceptre balloon T. Patankar, UK
  Trigeminal Neuralgia Caused by Dural Arteriovenous Fistula – venous congestion after transarterial/ transvenous embolization F. Dorn, DE
  The hidden nidus S. Lamin, UK
  Incomplete opening of a flow diverter: what to do? P. Mordasini, CH